MedPath
NMPA Approval

Dobutamine Hydrochloride Injection

国药准字H20249223

October 29, 2024

Drug Information

盐酸多巴酚丁胺注射液

注射剂

5ml:100mg(按C₁₈H₂₃NO₃计)

化学药品

October 29, 2024

Company Information

Applicant Company

浙江省宁波市奉化区方桥街道恒学路259号

Manufacturing Company

浙江省金华市婺城区汤溪镇永湖街788号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸多巴酚丁胺注射液 - NMPA 批准文号 | MedPath